SW · HBMN.SW
HBM Healthcare Investments AG
- Sector
- Financial Services · Asset Management
- Headquarters
- Zug 6301
- Website
- hbmhealthcare.com
Price · as of 2025-03-31
$235.00
Market cap 1.48B
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $599.83 | +155.25% |
| Intrinsic Value(DCF) | $401,737.71 | +170,852.22% |
| Graham-Dodd Method(GD) | $255.42 | +8.69% |
| Graham Formula(GF) | $1,656.82 | +605.03% |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2011 | $29.54 | $30.59 | $0.00 | $31.22 | $712.76 |
| 2012 | $24.54 | $33.71 | $0.00 | $46.19 | |
| 2013 | $34.42 | $123.58 | $45.88 | $105.00 | |
| 2014 | $53.02 | $112.85 | $6.45 | $311.57 | $14,318.62 |
| 2015 | $68.46 | $68.72 | $2.04 | $253.21 | $0.00 |
| 2016 | $67.16 | $136.17 | $588.27 | $65.82 | $0.00 |
| 2017 | $81.27 | $118.90 | $0.00 | $163.48 | $7,827.39 |
| 2018 | $123.07 | $85.30 | $0.00 | $160.77 | $0.00 |
| 2019 | $139.65 | $216.34 | $0.00 | $257.24 | $2,486.42 |
| 2020 | $186.62 | $192.65 | $0.00 | $339.55 | $0.00 |
| 2021 | $290.49 | $778.33 | $0.00 | $852.79 | $32,868.11 |
| 2022 | $230.82 | $118.70 | $0.00 | $229.46 | $1,084.65 |
| 2023 | $182.46 | $182.25 | $0.00 | $149.65 | |
| 2024 | $191.69 | $154.41 | $195.01 | $245.02 | |
| 2025 | $169.24 | $599.83 | $19,402.42 | $255.42 | $1,656.82 |
AI valuation
Our deep-learning model estimates HBM Healthcare Investments AG's (HBMN.SW) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $599.83
- Current price
- $235.00
- AI upside
- +155.25%
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$401,737.71
+170,852.22% upside
Graham-Dodd
$255.42
+8.69% upside
Graham Formula
$1,656.82
+605.03% upside
About HBM Healthcare Investments AG
HBM Healthcare Investments AG specializes in fund of funds and direct investments in middle market and mature companies. The fund prefers to invest in start up, early stage, mid stage, mid venture, late venture, and late stage private companies, unlisted emerging companies, small cap public companies, buyouts, growth capital, and private investment in public equities (PIPES). Within fund of funds, it invests in venture capital funds. It also seeks to finance spin-offs of product lines or departments from larger corporations and the expansion or restructuring of established companies, seed stages, venture capital, expansion capital stages, spin-offs, and buyouts. The fund prefers to invest in the private and public companies in the healthcare sector with a focus on human medicine, drugs, pharma , biopharma, biotechnology, diagnostics, medical technology, and related industries. It seeks to make initial investments in companies whose primary products are in clinical development or the immediately preceding stage. The fund typically invests globally with a focus on Asia Pacific, Asia, North America, and Europe. In case of public companies, it focuses on those which originate from its private portfolio. The fund increases its investment in portfolio companies by participating in a follow-on financing or after the portfolio company's IPO. It may acquire majority participations in portfolio companies, usually takes a seat on the portfolio company's Board of Directors, and largely makes equity investments but may also invest through other instruments including convertible bonds, debt securities, structured products, and derivatives. The fund exits its portfolio companies through trade sale or IPO.
- CEO
- Andreas Wicki
- Employees
- 0
- Beta
- 0.89
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($401,737.71 ÷ $235.00) − 1 = +170,852.22% (DCF, example).